 | • レポートコード：QYR2104Z4857 • 出版社/出版日：QYResearch / 2021年4月10日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、向精神薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗うつ薬、抗精神病薬、覚醒剤、抗不安薬、気分安定薬）、用途別市場規模（病院薬局、ドラッグストア、小売店、Eコマース）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・向精神薬の市場動向 ・企業の競争状況、市場シェア ・向精神薬の種類別市場規模（抗うつ薬、抗精神病薬、覚醒剤、抗不安薬、気分安定薬） ・向精神薬の用途別市場規模（病院薬局、ドラッグストア、小売店、Eコマース） ・向精神薬の北米市場規模2016-2027（アメリカ、カナダ） ・向精神薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・向精神薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・向精神薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・向精神薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Teva Pharmaceuticals、Novartis、Mylan、AstraZeneca、Sun Pharmaceuticals） ・結論 |
Psychotropic pharmaceutical is a chemical substance that changes brain function and results in alterations in perception, mood, consciousness, cognition or behavior.
The global psychotropic pharmaceuticals market is expected to grow rapidly over the forecast period owing to the raising prevalence of mental disorders.
Market Analysis and Insights: Global Psychotropic Pharmaceuticals Market
The global Psychotropic Pharmaceuticals market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Psychotropic Pharmaceuticals market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Psychotropic Pharmaceuticals market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Psychotropic Pharmaceuticals market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Psychotropic Pharmaceuticals market.
Global Psychotropic Pharmaceuticals Scope and Market Size
Psychotropic Pharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Psychotropic Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Anti-Depressants
Anti-Psychotics
Stimulants
Anxiolytics
Mood Stabilizers
Segment by Application
Hospital Pharmacies
Drug Stores
Retail Stores
E-Commerce
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Teva Pharmaceuticals
Novartis
Mylan
AstraZeneca
Sun Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psychotropic Pharmaceuticals Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-Depressants
1.2.3 Anti-Psychotics
1.2.4 Stimulants
1.2.5 Anxiolytics
1.2.6 Mood Stabilizers
1.3 Market by Application
1.3.1 Global Psychotropic Pharmaceuticals Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Stores
1.3.5 E-Commerce
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Psychotropic Pharmaceuticals Market Perspective (2016-2027)
2.2 Psychotropic Pharmaceuticals Growth Trends by Regions
2.2.1 Psychotropic Pharmaceuticals Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Psychotropic Pharmaceuticals Historic Market Share by Regions (2016-2021)
2.2.3 Psychotropic Pharmaceuticals Forecasted Market Size by Regions (2022-2027)
2.3 Psychotropic Pharmaceuticals Industry Dynamic
2.3.1 Psychotropic Pharmaceuticals Market Trends
2.3.2 Psychotropic Pharmaceuticals Market Drivers
2.3.3 Psychotropic Pharmaceuticals Market Challenges
2.3.4 Psychotropic Pharmaceuticals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psychotropic Pharmaceuticals Players by Revenue
3.1.1 Global Top Psychotropic Pharmaceuticals Players by Revenue (2016-2021)
3.1.2 Global Psychotropic Pharmaceuticals Revenue Market Share by Players (2016-2021)
3.2 Global Psychotropic Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Psychotropic Pharmaceuticals Revenue
3.4 Global Psychotropic Pharmaceuticals Market Concentration Ratio
3.4.1 Global Psychotropic Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psychotropic Pharmaceuticals Revenue in 2020
3.5 Psychotropic Pharmaceuticals Key Players Head office and Area Served
3.6 Key Players Psychotropic Pharmaceuticals Product Solution and Service
3.7 Date of Enter into Psychotropic Pharmaceuticals Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Psychotropic Pharmaceuticals Breakdown Data by Type
4.1 Global Psychotropic Pharmaceuticals Historic Market Size by Type (2016-2021)
4.2 Global Psychotropic Pharmaceuticals Forecasted Market Size by Type (2022-2027)
5 Psychotropic Pharmaceuticals Breakdown Data by Application
5.1 Global Psychotropic Pharmaceuticals Historic Market Size by Application (2016-2021)
5.2 Global Psychotropic Pharmaceuticals Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Psychotropic Pharmaceuticals Market Size (2016-2027)
6.2 North America Psychotropic Pharmaceuticals Market Size by Type
6.2.1 North America Psychotropic Pharmaceuticals Market Size by Type (2016-2021)
6.2.2 North America Psychotropic Pharmaceuticals Market Size by Type (2022-2027)
6.2.3 North America Psychotropic Pharmaceuticals Market Size by Type (2016-2027)
6.3 North America Psychotropic Pharmaceuticals Market Size by Application
6.3.1 North America Psychotropic Pharmaceuticals Market Size by Application (2016-2021)
6.3.2 North America Psychotropic Pharmaceuticals Market Size by Application (2022-2027)
6.3.3 North America Psychotropic Pharmaceuticals Market Size by Application (2016-2027)
6.4 North America Psychotropic Pharmaceuticals Market Size by Country
6.4.1 North America Psychotropic Pharmaceuticals Market Size by Country (2016-2021)
6.4.2 North America Psychotropic Pharmaceuticals Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Psychotropic Pharmaceuticals Market Size (2016-2027)
7.2 Europe Psychotropic Pharmaceuticals Market Size by Type
7.2.1 Europe Psychotropic Pharmaceuticals Market Size by Type (2016-2021)
7.2.2 Europe Psychotropic Pharmaceuticals Market Size by Type (2022-2027)
7.2.3 Europe Psychotropic Pharmaceuticals Market Size by Type (2016-2027)
7.3 Europe Psychotropic Pharmaceuticals Market Size by Application
7.3.1 Europe Psychotropic Pharmaceuticals Market Size by Application (2016-2021)
7.3.2 Europe Psychotropic Pharmaceuticals Market Size by Application (2022-2027)
7.3.3 Europe Psychotropic Pharmaceuticals Market Size by Application (2016-2027)
7.4 Europe Psychotropic Pharmaceuticals Market Size by Country
7.4.1 Europe Psychotropic Pharmaceuticals Market Size by Country (2016-2021)
7.4.2 Europe Psychotropic Pharmaceuticals Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Psychotropic Pharmaceuticals Market Size (2016-2027)
8.2 Asia-Pacific Psychotropic Pharmaceuticals Market Size by Type
8.2.1 Asia-Pacific Psychotropic Pharmaceuticals Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Psychotropic Pharmaceuticals Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Psychotropic Pharmaceuticals Market Size by Type (2016-2027)
8.3 Asia-Pacific Psychotropic Pharmaceuticals Market Size by Application
8.3.1 Asia-Pacific Psychotropic Pharmaceuticals Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Psychotropic Pharmaceuticals Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Psychotropic Pharmaceuticals Market Size by Application (2016-2027)
8.4 Asia-Pacific Psychotropic Pharmaceuticals Market Size by Region
8.4.1 Asia-Pacific Psychotropic Pharmaceuticals Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Psychotropic Pharmaceuticals Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Psychotropic Pharmaceuticals Market Size (2016-2027)
9.2 Latin America Psychotropic Pharmaceuticals Market Size by Type
9.2.1 Latin America Psychotropic Pharmaceuticals Market Size by Type (2016-2021)
9.2.2 Latin America Psychotropic Pharmaceuticals Market Size by Type (2022-2027)
9.2.3 Latin America Psychotropic Pharmaceuticals Market Size by Type (2016-2027)
9.3 Latin America Psychotropic Pharmaceuticals Market Size by Application
9.3.1 Latin America Psychotropic Pharmaceuticals Market Size by Application (2016-2021)
9.3.2 Latin America Psychotropic Pharmaceuticals Market Size by Application (2022-2027)
9.3.3 Latin America Psychotropic Pharmaceuticals Market Size by Application (2016-2027)
9.4 Latin America Psychotropic Pharmaceuticals Market Size by Country
9.4.1 Latin America Psychotropic Pharmaceuticals Market Size by Country (2016-2021)
9.4.2 Latin America Psychotropic Pharmaceuticals Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psychotropic Pharmaceuticals Market Size (2016-2027)
10.2 Middle East & Africa Psychotropic Pharmaceuticals Market Size by Type
10.2.1 Middle East & Africa Psychotropic Pharmaceuticals Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Psychotropic Pharmaceuticals Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Psychotropic Pharmaceuticals Market Size by Type (2016-2027)
10.3 Middle East & Africa Psychotropic Pharmaceuticals Market Size by Application
10.3.1 Middle East & Africa Psychotropic Pharmaceuticals Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Psychotropic Pharmaceuticals Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Psychotropic Pharmaceuticals Market Size by Application (2016-2027)
10.4 Middle East & Africa Psychotropic Pharmaceuticals Market Size by Country
10.4.1 Middle East & Africa Psychotropic Pharmaceuticals Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Psychotropic Pharmaceuticals Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Teva Pharmaceuticals
11.1.1 Teva Pharmaceuticals Company Details
11.1.2 Teva Pharmaceuticals Business Overview
11.1.3 Teva Pharmaceuticals Psychotropic Pharmaceuticals Introduction
11.1.4 Teva Pharmaceuticals Revenue in Psychotropic Pharmaceuticals Business (2016-2021)
11.1.5 Teva Pharmaceuticals Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Psychotropic Pharmaceuticals Introduction
11.2.4 Novartis Revenue in Psychotropic Pharmaceuticals Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Psychotropic Pharmaceuticals Introduction
11.3.4 Mylan Revenue in Psychotropic Pharmaceuticals Business (2016-2021)
11.3.5 Mylan Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Psychotropic Pharmaceuticals Introduction
11.4.4 AstraZeneca Revenue in Psychotropic Pharmaceuticals Business (2016-2021)
11.4.5 AstraZeneca Recent Development
11.5 Sun Pharmaceuticals
11.5.1 Sun Pharmaceuticals Company Details
11.5.2 Sun Pharmaceuticals Business Overview
11.5.3 Sun Pharmaceuticals Psychotropic Pharmaceuticals Introduction
11.5.4 Sun Pharmaceuticals Revenue in Psychotropic Pharmaceuticals Business (2016-2021)
11.5.5 Sun Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Psychotropic Pharmaceuticals Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anti-Depressants
Table 3. Key Players of Anti-Psychotics
Table 4. Key Players of Stimulants
Table 5. Key Players of Anxiolytics
Table 6. Key Players of Mood Stabilizers
Table 7. Global Psychotropic Pharmaceuticals Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Psychotropic Pharmaceuticals Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Psychotropic Pharmaceuticals Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Psychotropic Pharmaceuticals Market Share by Regions (2016-2021)
Table 11. Global Psychotropic Pharmaceuticals Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Psychotropic Pharmaceuticals Market Share by Regions (2022-2027)
Table 13. Psychotropic Pharmaceuticals Market Trends
Table 14. Psychotropic Pharmaceuticals Market Drivers
Table 15. Psychotropic Pharmaceuticals Market Challenges
Table 16. Psychotropic Pharmaceuticals Market Restraints
Table 17. Global Psychotropic Pharmaceuticals Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Psychotropic Pharmaceuticals Market Share by Players (2016-2021)
Table 19. Global Top Psychotropic Pharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psychotropic Pharmaceuticals as of 2020)
Table 20. Ranking of Global Top Psychotropic Pharmaceuticals Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Psychotropic Pharmaceuticals Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Psychotropic Pharmaceuticals Product Solution and Service
Table 24. Date of Enter into Psychotropic Pharmaceuticals Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Psychotropic Pharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Psychotropic Pharmaceuticals Revenue Market Share by Type (2016-2021)
Table 28. Global Psychotropic Pharmaceuticals Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Psychotropic Pharmaceuticals Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Psychotropic Pharmaceuticals Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Psychotropic Pharmaceuticals Revenue Market Share by Application (2016-2021)
Table 32. Global Psychotropic Pharmaceuticals Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Psychotropic Pharmaceuticals Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Psychotropic Pharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Psychotropic Pharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Psychotropic Pharmaceuticals Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Psychotropic Pharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Psychotropic Pharmaceuticals Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Psychotropic Pharmaceuticals Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Psychotropic Pharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Psychotropic Pharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Psychotropic Pharmaceuticals Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Psychotropic Pharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Psychotropic Pharmaceuticals Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Psychotropic Pharmaceuticals Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Psychotropic Pharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Psychotropic Pharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Psychotropic Pharmaceuticals Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Psychotropic Pharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Psychotropic Pharmaceuticals Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Psychotropic Pharmaceuticals Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Psychotropic Pharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Psychotropic Pharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Psychotropic Pharmaceuticals Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Psychotropic Pharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Psychotropic Pharmaceuticals Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Psychotropic Pharmaceuticals Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Psychotropic Pharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Psychotropic Pharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Psychotropic Pharmaceuticals Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Psychotropic Pharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Psychotropic Pharmaceuticals Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Psychotropic Pharmaceuticals Market Size by Country (2022-2027) & (US$ Million)
Table 64. Teva Pharmaceuticals Company Details
Table 65. Teva Pharmaceuticals Business Overview
Table 66. Teva Pharmaceuticals Psychotropic Pharmaceuticals Product
Table 67. Teva Pharmaceuticals Revenue in Psychotropic Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 68. Teva Pharmaceuticals Recent Development
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Psychotropic Pharmaceuticals Product
Table 72. Novartis Revenue in Psychotropic Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. Mylan Company Details
Table 75. Mylan Business Overview
Table 76. Mylan Psychotropic Pharmaceuticals Product
Table 77. Mylan Revenue in Psychotropic Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 78. Mylan Recent Development
Table 79. AstraZeneca Company Details
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca Psychotropic Pharmaceuticals Product
Table 82. AstraZeneca Revenue in Psychotropic Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 83. AstraZeneca Recent Development
Table 84. Sun Pharmaceuticals Company Details
Table 85. Sun Pharmaceuticals Business Overview
Table 86. Sun Pharmaceuticals Psychotropic Pharmaceuticals Product
Table 87. Sun Pharmaceuticals Revenue in Psychotropic Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 88. Sun Pharmaceuticals Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Psychotropic Pharmaceuticals Market Share by Type: 2020 VS 2027
Figure 2. Anti-Depressants Features
Figure 3. Anti-Psychotics Features
Figure 4. Stimulants Features
Figure 5. Anxiolytics Features
Figure 6. Mood Stabilizers Features
Figure 7. Global Psychotropic Pharmaceuticals Market Share by Application: 2020 VS 2027
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Drug Stores Case Studies
Figure 10. Retail Stores Case Studies
Figure 11. E-Commerce Case Studies
Figure 12. Psychotropic Pharmaceuticals Report Years Considered
Figure 13. Global Psychotropic Pharmaceuticals Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Psychotropic Pharmaceuticals Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Psychotropic Pharmaceuticals Market Share by Regions: 2020 VS 2027
Figure 16. Global Psychotropic Pharmaceuticals Market Share by Regions (2022-2027)
Figure 17. Global Psychotropic Pharmaceuticals Market Share by Players in 2020
Figure 18. Global Top Psychotropic Pharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psychotropic Pharmaceuticals as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Psychotropic Pharmaceuticals Revenue in 2020
Figure 20. Global Psychotropic Pharmaceuticals Revenue Market Share by Type (2016-2021)
Figure 21. Global Psychotropic Pharmaceuticals Revenue Market Share by Type (2022-2027)
Figure 22. North America Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Psychotropic Pharmaceuticals Market Share by Type (2016-2027)
Figure 24. North America Psychotropic Pharmaceuticals Market Share by Application (2016-2027)
Figure 25. North America Psychotropic Pharmaceuticals Market Share by Country (2016-2027)
Figure 26. United States Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Psychotropic Pharmaceuticals Market Share by Type (2016-2027)
Figure 30. Europe Psychotropic Pharmaceuticals Market Share by Application (2016-2027)
Figure 31. Europe Psychotropic Pharmaceuticals Market Share by Country (2016-2027)
Figure 32. Germany Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Psychotropic Pharmaceuticals Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Psychotropic Pharmaceuticals Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Psychotropic Pharmaceuticals Market Share by Region (2016-2027)
Figure 42. China Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Psychotropic Pharmaceuticals Market Share by Type (2016-2027)
Figure 50. Latin America Psychotropic Pharmaceuticals Market Share by Application (2016-2027)
Figure 51. Latin America Psychotropic Pharmaceuticals Market Share by Country (2016-2027)
Figure 52. Mexico Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Psychotropic Pharmaceuticals Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Psychotropic Pharmaceuticals Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Psychotropic Pharmaceuticals Market Share by Country (2016-2027)
Figure 58. Turkey Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Psychotropic Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Teva Pharmaceuticals Revenue Growth Rate in Psychotropic Pharmaceuticals Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Psychotropic Pharmaceuticals Business (2016-2021)
Figure 63. Mylan Revenue Growth Rate in Psychotropic Pharmaceuticals Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Psychotropic Pharmaceuticals Business (2016-2021)
Figure 65. Sun Pharmaceuticals Revenue Growth Rate in Psychotropic Pharmaceuticals Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed